Ricky Ruiqi Zhang
Overview
Explore the profile of Ricky Ruiqi Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
1039
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wen K, Cai J, Fan X, Zhang X, Luo C, Tang K, et al.
Front Cell Infect Microbiol
. 2023 Aug;
13:1213806.
PMID: 37645378
Introduction: Therapeutic monoclonal antibodies (mAbs) against the SARS-CoV-2 spike protein have been shown to improve the outcome of severe COVID-19 patients in clinical trials. However, novel variants with spike protein...
2.
Tam A, Zhang R, Lung K, Liu R, Leung K, Liu D, et al.
Clin Infect Dis
. 2022 Jun;
76(3):e216-e226.
PMID: 35762834
Background: Early antiviral therapy was effective in the treatment of coronavirus disease 2019 (COVID-19). We assessed the efficacy and safety of combined interferon beta-1b and remdesivir treatment in hospitalized COVID-19...
3.
Lu L, Chu A, Zhang R, Chan W, Ip J, Tsoi H, et al.
EBioMedicine
. 2021 Aug;
71:103544.
PMID: 34419925
Background: Several SARS-CoV-2 lineages with spike receptor binding domain (RBD) N501Y mutation have spread globally. We evaluated the impact of N501Y on neutralizing activity of COVID-19 convalescent sera and on...
4.
Chen L, Lu L, Choi C, Cai J, Tsoi H, Chu A, et al.
Clin Infect Dis
. 2021 Jul;
74(9):1623-1630.
PMID: 34309648
Background: Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages with mutations at the spike protein receptor binding domain (RBD) have reduced susceptibility to antibody neutralization, and have been classified...
5.
Wong C, Luk H, Lai W, Lau Y, Zhang R, Wong A, et al.
Circ J
. 2020 Sep;
84(11):2027-2031.
PMID: 32981925
Background: SARS-CoV-2 infection is associated with myocardial injury, but there is a paucity of experimental platforms for the condition. Methods and results: Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) infected by...
6.
Hung I, Yap D, Yip T, Zhang R, To K, Chan K, et al.
Clin Infect Dis
. 2020 Jun;
73(2):e304-e311.
PMID: 32556176
Background: Patients on dialysis are hyporesponsive to the hepatitis B virus vaccines (HBVv). We examined intradermal (ID) HBVv Sci-B-Vac, with topical Toll-like receptor 7 (TLR7) agonist imiquimod pretreatment in dialysis...
7.
Hung I, Cheng V, Li X, Tam A, Hung D, Chiu K, et al.
Lancet Infect Dis
. 2020 Jun;
20(9):1051-1060.
PMID: 32539986
Background: A cruise ship is a closed-off environment that simulates the basic functioning of a city in terms of living conditions and interpersonal interactions. Thus, the Diamond Princess cruise ship,...
8.
Hung I, Lung K, Tso E, Liu R, Chung T, Chu M, et al.
Lancet
. 2020 May;
395(10238):1695-1704.
PMID: 32401715
Background: Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, lopinavir-ritonavir, and ribavirin for treating patients...